Trademark: 79342738
Status Date
Tuesday, March 5, 2024
Registration Number
7318047
Registration Date
Tuesday, March 5, 2024
Filing Date
Friday, April 29, 2022
Published for Opposition
Tuesday, December 19, 2023
9 Downloadable or recorded software for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors; downloadable application software in the field of clinical biology for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors
5 Pharmaceutical products, namely, pharmaceutical products for use in the treatment of cancer; chemical preparations for medical and pharmaceutical use, namely for use in the treatment of cancer; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for providing information on diagnostics or identification of biological systems for medical use; immunological reagents for medical use; biological reagents for medical diagnosis; diagnostic kits comprising medical diagnostic reagents and medical diagnostic tests for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
44 Medical analysis services for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; medical assistance; medical diagnostics and diagnostics in the field of medicine, namely in the fields of immuno-oncology and cancer research; genetic analysis services, namely in the fields of immuno-oncology and cancer research
42 Research, development, technical design and scientific testing services, namely scientific research for relating to cancer treatment; industrial analysis and research services in the fields of immuno-oncology and cancer research; clinical trial services, namely providing laboratory testing in clinical trials; tests in laboratories, namely in the fields of immuno-oncology and cancer research; development of testing methods for others in the fields of immuno-oncology and cancer research; research, development, technical design, testing, consultancy and analysis services in the field of immuno-oncology; research services in the field of genome and immune index analysis; design and development of software in the field of biology
Mar 5, 2024
Notice Of Registration Confirmation Emailed
Mar 5, 2024
Registered-Principal Register
Dec 19, 2023
Notification Processed By Ib
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Published For Opposition
Dec 11, 2023
Notification Of Possible Opposition - Processed By Ib
Nov 29, 2023
Notification Of Possible Opposition Sent To Ib
Nov 29, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Nov 22, 2023
Notification Of Possible Opposition Sent To Ib
Nov 22, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 9, 2023
Approved For Pub - Principal Register
Oct 19, 2023
Teas/Email Correspondence Entered
Oct 18, 2023
Correspondence Received In Law Office
Oct 18, 2023
Teas Response To Office Action Received
May 10, 2023
Refusal Processed By Ib
Apr 18, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Apr 18, 2023
Refusal Processed By Mpu
Feb 28, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Feb 27, 2023
Non-Final Action Written
Feb 17, 2023
Assigned To Examiner
Jun 21, 2022
Application Filing Receipt Mailed
Jun 17, 2022
New Application Office Supplied Data Entered
Jun 16, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
